ABEO Stock Analysis: Buy, Sell, or Hold?
ABEO - Abeona Therapeutics Inc. Common Stock
$5.09
0.01 (0.20%)
▲
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Mar 19, 2026
Get Alerted When ABEO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called ABEO this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ABEO shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: ABEO shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: ABEO is currently trading at $5.09, which is considered oversold relative to its 30-day fair value range of $5.09 to $5.38.
Technical Outlook: Technically, ABEO is in a downtrend. Immediate support is located at $4.79, while resistance sits at $5.68.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $20.64 (+306.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ABEO is in a downtrend. Immediate support is located at $4.79, while resistance sits at $5.68.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $20.64 (+306.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$5.09 -
$5.38
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 306.4% below Wall St target ($20.64)
Fair Price Analysis
30-Day Fair Range
$5.09 -
$5.38
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$4.79
Resistance Level
$5.69
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-72.57
Wall Street Target
$20.64
(+306.4%)
Revenue Growth (YoY)
-100.0%
Profit Margin
20587.5%
Last updated: January 31, 2026 2:51 AM ET
Data refreshes hourly during market hours. Next update: 3:51 AM
Data refreshes hourly during market hours. Next update: 3:51 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABEO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Vishwas Seshadri
SELL
249 shares
2025-10-16
Vishwas Seshadri
SELL
25000 shares
2025-09-30
Brendan M O'malley
SELL
9366 shares
2025-09-29
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$22 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$141 | 59 HOLD |
Advanced ABEO Option Strategies
Professional options setups generated by AI based on today's ABEO price and gamma walls.
